GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Beta

Median Diagnostics (XKRX:233250) Beta : 0.18 (As of Apr. 03, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-04-03), Median Diagnostics's Beta is 0.18.


Median Diagnostics Beta Historical Data

The historical data trend for Median Diagnostics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics Beta Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.57 -0.13 0.10 0.42 -0.40

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.57 -0.13 0.10 0.42 -0.40

Competitive Comparison of Median Diagnostics's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Median Diagnostics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Diagnostics's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Median Diagnostics's Beta distribution charts can be found below:

* The bar in red indicates where Median Diagnostics's Beta falls into.


;
;

Median Diagnostics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Median Diagnostics  (XKRX:233250) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Median Diagnostics Beta Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines